Health & bio
Less Than 10% of Eligible Patients Use GLP-1
GLP-1 penetration among eligible patients remains below 10%, leaving significant room for multiple market participants.
Primary sources · 1
GLP-1 penetration among eligible patients remains below 10%, leaving significant room for multiple market participants.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.